glutathione is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Several analytical methods can quantify glutathione, including high-performance liquid chromatography (HPLC) with UV or fluorescence detection for separating GSH and GSSG. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) offers higher specificity and sensitivity, often detecting nanomolar concentrations. The enzymatic recycling assay, often called the Tietze method, measures total glutathione by coupling reduction of GSSG to a colorimetric or fluorometric readout. Capillary electrophoresis and electrochemical detection are also used in specialized laboratories. Each method has distinct advantages and limitations regarding throughput, cost, and susceptibility to interference.
Interpreting glutathione measurements requires attention to pre-analytical variables. The GSSG concentration in a sample can rise artificially during storage or processing, making the GSH/GSSG ratio unreliable if not controlled. Reference ranges vary by specimen type, assay, and population, so comparisons across studies are difficult. Plasma glutathione is low and sensitive to hemolysis, while whole blood reflects primarily erythrocyte content. Many studies measure total glutathione rather than the reduced and oxidized forms separately, which limits conclusions about redox status.
Glutathione participates in detoxification reactions, amino acid transport, and the maintenance of protein thiols. It serves as a cofactor for several enzymes, including glutathione peroxidases and glutathione S-transferases. In research literature, altered glutathione status appears in studies of aging, infection, metabolic stress, and environmental exposure. Whether low glutathione is a cause, consequence, or marker of such conditions often remains unresolved. Direct measurement in blood or tissue provides a snapshot, but results depend on sample handling, timing, and the method used.
Glutathione is a small tripeptide made of glutamic acid, cysteine, and glycine. Its cysteine thiol group allows reversible oxidation and reduction, making it central to cellular redox chemistry. The reduced form, often abbreviated GSH, predominates inside most cells, while the oxidized disulfide form, GSSG, forms when two GSH molecules react. The ratio of GSH to GSSG is widely used as an indicator of oxidative stress in laboratory research, though it does not by itself diagnose a clinical condition.
Biosynthesis occurs in two ATP-dependent steps. The enzyme glutamate-cysteine ligase joins glutamate and cysteine, forming gamma-glutamylcysteine; glutathione synthetase then adds glycine to produce the complete tripeptide. Because the peptide bond from glutamate uses the gamma-carboxyl group, glutathione resists digestion by many ordinary peptidases. Tissues vary in synthesis capacity, and the liver generally contains high concentrations relative to many other organs. This uneven distribution contributes to organ-specific differences in redox buffering and affects how experimental results are interpreted across tissue types.
| Property | Value | Notes |
|---|---|---|
| Common analytical method | LC-MS/MS or HPLC | Separation of GSH and GSSG |
| Limit of detection | Nanomolar range | Method dependent |
| Typical sample storage | -80 °C | For biological matrices |
| Common reducing agent | TCEP or DTT | Prevents oxidation during processing |
| Common synonym | Gamma-glutamylcysteinylglycine | Systematic name |
In cells, glutathione helps maintain the reducing environment of the cytosol and supports enzymes that counteract reactive oxygen species. It acts as a cofactor for glutathione peroxidases, which reduce hydrogen peroxide and lipid peroxides, and for glutathione S-transferases, which conjugate electrophiles. The ratio of GSH to GSSG is often used as an indicator of oxidative stress, although the ratio can vary by compartment and cell type. Glutathione also stores cysteine, an amino acid that can be limiting for protein synthesis and antioxidant defense.
Synthesis occurs in two ATP-dependent steps. The enzyme glutamate-cysteine ligase joins glutamate and cysteine to form gamma-glutamylcysteine, and glutathione synthetase adds glycine. The first step is rate-limiting and is influenced by cysteine availability and feedback inhibition by GSH. Breakdown involves gamma-glutamyl transferase and subsequent peptidases, which release constituent amino acids for reuse. Because turnover differs among tissues, measurements from blood, plasma, and tissues are not directly interchangeable. Research continues to clarify how compartment-specific pools are regulated in health and disease.
Glutathione supports detoxification by conjugating reactive electrophiles through glutathione S-transferases. The resulting conjugates are processed and exported, often after further metabolism. It also stores cysteine, transports amino acids across membranes through the gamma-glutamyl cycle, and assists in the maturation of iron-sulfur clusters and some prostaglandins. In plants, animals, and many microbes, the molecule appears in similar roles, but concentrations vary enormously between tissues. Liver, kidney, and red blood cells tend to contain high amounts, while blood plasma contains much less.
Glutathione is a small tripeptide built from glutamate, cysteine, and glycine. The peptide bond between glutamate and cysteine uses the gamma-carboxyl group, a linkage that resists ordinary peptidases. Cells make it in two ATP-dependent steps: gamma-glutamylcysteine synthetase joins glutamate and cysteine, then glutathione synthetase adds glycine. The pathway is feedback-inhibited by glutathione itself, so intracellular levels tend to stay within a narrow range. Because cysteine is often limiting, sulfur amino acid supply influences how much glutathione a cell can produce.
== Career == Chen began her career at the Institute of Chemistry of Academia Sinica as assistant research fellow in 1999. She was the Director of the Institute of Chemistry from 2013 to 2019, and is currently a Distinguished Research Fellow. She is also an adjunct professor at National Taiwan University, National Chiayi University, National Taiwan Ocean University, and National Chung Hsing University. She conducts research in mass spectrometry-based bioinformatics, in relation to understanding diseases such as cancer. Since 2016, Chen has participated in the US Cancer Moonshot Initiative, providing proteogenomics expertise as representative of Academia Sinica. She is the project investigator for the Taiwan Cancer Moonshot Project, which analyzes multiomic data related to gastric cancer. She participates in the Chromosome-centric Human Proteome Project, and is the group lead of chromosome 4. Chen served as president for the Human Proteome Organization (2021-2022), the Taiwan Proteomics Society, and the Taiwan Society for Mass Spectrometry (2012-2015). She has been a council member of the Asia Oceania Human Proteome Organization since 2019. She current serves as executive director of the Taiwan Proteomics Society (2021-2023), and the Taiwan Society for Mass Spectrometry. She served on editorial boards of European Journal of Mass Spectrometry, Journal of Proteome Research, and Frontiers in Analytical Chemistry, and currently serves on the Executive Advisory Board of Proteomics.
Yet the symbiosis raised a century-long puzzle: if multiple fungi adopted algal partners independently, the "lichen condition" might be polyphyletic. This question of how many times lichenization evolved remained speculative until the advent of molecular phylogenetics. Early lichenologists such as Walter Watson warned that symbiosis can so remodel a fungus that its ancestry becomes hard to trace. Modern molecular studies confirm the problem: convergent thallus forms have evolved repeatedly and even been lost again, making ancestry hard to infer.
== Production and effects == Artificial production methods of radionuclides include neutron sources such as nuclear reactors, as well as particle accelerators such as cyclotrons. The radiation from radionuclides generally has a harmful effect on organisms including humans, although low levels of exposure occur naturally. The degree of harm depends on the nature and extent of the radiation (alpha, beta, gamma, or neutron), the amount and nature of exposure (close contact, inhalation or ingestion), and the element's biochemical properties (toxicity). Increased risk of cancer is unavoidable, and worse cases induce cancer, chronic radiation syndrome or acute radiation syndrome. Radionuclides can be used as weapons by the fallout effects of nuclear weapons and by radiological weapons. Radionuclides are used in nuclear medicine for both diagnosis and treatment. The term “theranostics” (or “theragnostics”) refers to the combination of diagnosis and therapy of a disease within a single medical procedure or technique. An imaging tracer made with radionuclides is a radioactive tracer. Radionuclide therapy is a form of radiotherapy. A pharmaceutical drug made with radionuclides is called a radiopharmaceutical.
=== Polyendocrine metabolic ovarian syndrome === In those with polyendocrine metabolic ovarian syndrome (PMOS), tentative evidence shows that metformin use increases the rate of live births. This includes those who have not been able to get pregnant with clomiphene. Metformin does not appear to change the risk of miscarriage. A number of other benefits have also been found both during pregnancy and in nonpregnant people with PMOS. In an updated Cochrane review on metformin versus placebo/no treatment before or during IVF/ICSI in women with PMOS, no conclusive evidence of improved live birth rates was found. In long GnRH-agonist protocols there was uncertainty in the evidence of improved live birth rates but there could be increases in clinical pregnancy rate. In short GnRH-antagonist protocols metformin may reduce live birth rates with uncertainty on its effect on clinical pregnancy rate. Metformin may result in a reduction of OHSS but could come with a greater frequency of side effects. There was uncertainty as to metformin's impact on miscarriage. The evidence does not support general use during pregnancy for improving maternal and infant outcomes in obese women. The United Kingdom's National Institute for Health and Clinical Excellence recommended in 2004 that people with PMOS and a body mass index above 25 be given metformin for anovulation and infertility when other therapies fail to produce results.
Recombinant myoglobin for faux meat (Motif Foodworks) Recombinant leghemoglobin for faux meat (Impossible Foods) Recombinant whey protein for dairy replacement (Perfect Day) Recombinant casein protein for dairy replacements (Those Vegan Cowboys) Recombinant egg white (EVERY) Heme proteins such as myoglobin and hemoglobin give meat its characteristic texture, flavor, color, and aroma. The myoglobin and leghemoglobin ingredients can be used to replicate this property, despite them coming from a vat instead of meat.
Sources: en.wikipedia.org
On June 13, 2013, ESPN announced that they would end the broadcast of the ESPN 3D channel by the end of that year and would "...experiment with things like UHDTV." On June 26, 2013, Sharp announced the LC-70UD1U, which is a 70 in (180 cm) 4K Ultra HD TV. The LC-70UD1U is the world's first TV with THX 4K certification. On July 2, 2013, Jimmy Kimmel Live! recorded in 4K Ultra HD a performance by musical guest Karmin, and the video clip was used as demonstration material at Sony stores. On July 3, 2013, Sony announced the release of their 4K Ultra HD Media Player with a price of US$7.99 for rentals and US$29.99 for purchases. The 4K Ultra HD Media Player only worked with Sony's 4K Ultra HD TVs. On July 15, 2013, the CTA published CTA-861-F, a standard that applies to interfaces such as DVI, HDMI, and LVDS. The CTA-861-F standard adds support for several Ultra HD video formats and additional color spaces. On September 2, 2013 Acer announced the first smartphone, dubbed Liquid S2, capable of recording 4K video. On September 4, 2013, the HDMI Forum released the HDMI 2.0 specification, which supports 4K resolution at 60 fps. On the same day, Panasonic announced the Panasonic TC-L65WT600—the first 4K TV to support 4K resolution at 60 FPS. The Panasonic TC-L65WT600 has a 65 in (170 cm) screen, support for DisplayPort 1.2a, support for HDMI 2.0, an expected ship date of October, and a suggested retail price of US$5,999.
== Genetics == The most common causes are mutations in the RYR1 and SELENON genes. In these cases the inheritance is autosomal recessive. Less common recessive mutations causing this condition include those in the TTN, MEGF10 and CACNA1S genes. Automsomal dominant mutations associated with this disease include those in MYH7 and CACNA1S. The pathogenesis is not well understood at present.
==== Testosterone replacement therapy (TRT) and secondary polycythemia ==== Testosterone replacement therapy (TRT) causes secondary polycythemia by stimulating the body's natural pathways that regulate red blood cell production, rather than from an inherent bone marrow disorder. Testosterone increases the production of erythropoietin (EPO) in the kidneys, a hormone that signals the bone marrow to make more red blood cells. At the same time, testosterone suppresses the liver hormone hepcidin, which normally limits the absorption and mobilization of iron. With less hepcidin, iron becomes more available for hemoglobin synthesis, further fueling red blood cell production. This combination of increased EPO signaling and enhanced iron supply amplifies erythropoiesis, leading to elevated hematocrit and hemoglobin levels. The effect is most pronounced with injectable forms of testosterone that create high peak serum levels, which strongly stimulate these pathways. Because the mechanism is driven by a hormonal stimulus and not by a primary bone marrow abnormality, the condition is classified as secondary polycythemia. Clinically, this distinction is important, as TRT-induced secondary polycythemia resolves or improves with dose adjustment, delivery method changes, or therapeutic phlebotomy, whereas primary polycythemia reflects a chronic clonal disorder of hematopoietic stem cells.
Long-chain-fatty-acid—CoA ligase catalyzes the reaction between a fatty acid with ATP to give a fatty acyl adenylate, plus inorganic pyrophosphate, which then reacts with free coenzyme A to give a fatty acyl-CoA ester and AMP. If the fatty acyl-CoA has a long chain, then the carnitine shuttle must be utilized (shown in the table below): Acyl-CoA is transferred to the hydroxyl group of carnitine by carnitine palmitoyltransferase I, located on the cytosolic faces of the outer and inner mitochondrial membranes. Acyl-carnitine is shuttled inside by a carnitine-acylcarnitine translocase, as a carnitine is shuttled outside. Acyl-carnitine is converted back to acyl-CoA by carnitine palmitoyltransferase II, located on the interior face of the inner mitochondrial membrane. The liberated carnitine is shuttled back to the cytosol, as an acyl-carnitine is shuttled into the matrix. If the fatty acyl-CoA contains a short chain, these short-chain fatty acids can simply diffuse through the inner mitochondrial membrane.
Sources: en.wikipedia.org
The body contains trillions of cells, the fundamental unit of life. At maturity, there are roughly 30 trillion cells, and 38 trillion bacteria in the body, an estimate arrived at by totaling the cell numbers of all the organs of the body and cell types. The skin of the body is also host to billions of commensal organisms as well as immune cells. Not all parts of the body are made from cells. Cells sit in an extracellular matrix that consists of proteins such as collagen, surrounded by extracellular fluids. Each of the cells of the human body experiences, on average, tens of thousands of DNA damages per day. These damages can block genome replication or genome transcription, and if they are not repaired or are repaired incorrectly, they may lead to mutations, or other genome alterations that threaten cell viability.
=== CRISPR === STX-1150 is a potential CRISPR-based treatment for hypercholesterolemia. STX-1150 is a liver-targeted therapy designed to silence PCSK9 via a durable epigenetic mark and durably reduce low-density lipoprotein cholesterol (LDL-C) without DNA changes. In non-human primate tests, it reduced LDL-C by >50% and was effective for ~18 months following a single administration.
If a crystal has three axes at right angles to each other then, if they are equivalent, the crystal is isotropic, if two are equivalent and the third different, the crystal is uniaxial, and if all three are different, the crystal is biaxial. In 1822 John Herschel proposed a causal relationship between the handedness of quartz crystals (right- or left-handed) and the direction of their optical rotation. In 1840 Friedrich Ludwig Hünefeld described the first crystallization of a protein; Hünefeld obtained lamellar crystals (later identified as haemoglobin) by putting the blood of an earthworm between two slides.
=== 9 April === Ukraine started electricity exports for the first time since six months after the invasion. Energy exports had been stopped due to multiple strikes on the electrical infrastructure. Ukrainian Energy Minister Herman Halushchenko stated that the electrical system had been producing extra capacity for almost two months.
The biological activity of heparin within species 6–11 is unclear and further supports the idea that the main physiological role of heparin is not anticoagulation. These species do not possess any blood coagulation system similar to that present within the species listed 1–5. The above list also demonstrates how heparin has been highly evolutionarily conserved, with molecules of a similar structure being produced by a broad range of organisms belonging to many different phyla.
Sources: en.wikipedia.org
Glutathione oxidizes quickly when cells are disrupted or when samples sit at room temperature. Rapid processing or immediate freezing minimizes the conversion of GSH to GSSG. This step helps ensure that the measured ratio reflects the original biological state.
The Tietze assay is an enzymatic recycling method that measures total glutathione. It uses glutathione reductase to reduce GSSG back to GSH, which then reacts with a chromogen or fluorophore. The reaction cycles repeatedly, amplifying the signal for detection.
Yes, but the choice of blood fraction matters. Plasma or serum contains low glutathione levels and is easily affected by hemolysis. Whole blood mainly reflects the high glutathione content of erythrocytes, so results from different fractions are not directly comparable.
GSH is the reduced form of glutathione, with a free thiol group on cysteine. GSSG is the oxidized disulfide form, created when two GSH molecules become linked. The two forms exist together, and their balance is often reported as the GSH/GSSG ratio in laboratory studies.